This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Celanese (CE) Down 1.7% Since the Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celanese (CE) to Increase Price of Vinyl Acetate Monomer
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) Poised on Productivity Actions, Acquisitions
by Zacks Equity Research
Celanese Corporation's (CE) cost saving and productivity actions as well as acquisitions are expected to lend support to earnings in 2017. However, the company is exposed to pricing pressure.
Celanese (CE) to Raise Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
International Flavors (IFF) Q2 Earnings: A Beat in Store?
by Zacks Equity Research
International Flavors & Fragrances Inc. (IFF) second-quarter results will likely benefit from business expansion in emerging markets, solid product portfolio and focus on research and development.
Celanese (CE) Beats Earnings and Revenue Estimates in Q2
by Zacks Equity Research
Both Acetyl Chain and Materials Solutions units contributed to the strong performance of Celanese (CE) in the second quarter.
Celanese (CE) Scales New 52-Week High on Bright Prospects
by Zacks Equity Research
Celanese's (CE) shares are scaling new highs on solid prospects driven by the joint venture deal with Blackstone and the buyout of Nilit's business.
Celanese (CE) Board Clears New $1.5B Share Repurchase Program
by Zacks Equity Research
Celanese's board of directors approves $1.5 billion share repurchase program that represents approximately 11% of the company's outstanding shares.
Celanese (CE) to Hike Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese (CE) announced that it will increase the list and off-list selling prices for certain acetyl intermediate products including Vinyl Acetate Monomer and Acetic Anhydride.
Celanese (CE) to Raise Prices of Ethyl Acetate in Europe
by Zacks Equity Research
Celanese (CE) announced that it will increase the list and off-list selling prices for ethyl acetate in Europe by ???150 per MT.
Celanese (CE) Declares Price Hike for Selective Products
by Zacks Equity Research
Celanese Corporation (CE) said that it will increase the selling prices of selective products like Dibutyl Maleate (DBM), Dioctyl Maleate (DOM) and Plasticizer WVC 3800.
Celanese Corp (CE) Looks Good: Stock Adds 5.7% in Session
by Zacks Equity Research
Celanese Corp (CE) was a big mover last session, as the company saw its shares rise over 5% on the day.
Celanese, Blackstone Ink Deal to Form Acetate Tow JV
by Zacks Equity Research
Celanese (CE) and Blackstone have agreed to form a joint venture that will create a global acetate tow supplier.
The Greatest Buy and Hold Stock Investor of All Time
by Tracey Ryniec
Many value investors believe in buy and hold investing but it is a difficult strategy even for the best investors.
Celanese (CE) Updates on Ibn Sina JV Polyacetal Facility
by Zacks Equity Research
Celanese (CE) has provided an update on its Ibn Sina JV and construction of a polyacetal manufacturing plant in Saudi Arabia.
Celanese Closes Buyout of Nilit's Nylon Compounding Unit
by Zacks Equity Research
Celanese (CE) has closed its acquisition of the nylon compounding division of Nilit.
Celanese (CE) Beats Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Celanese Corporation (CE), a chemical and advanced materials producer, kept its earnings streak alive with a beat in first-quarter 2017.
Will Celanese Corp. Be a Suitable Pick for Value Investors?
by Zacks Equity Research
Let's put Celanese Corporation (CE) stock into this equation and find out if it is a good choice for value-oriented investors right now.
Celanese (CE) Scales New 52-Week High: What's Driving It?
by Zacks Equity Research
On Mar 15, Celanese Corporation's (CE) shares reached a new 52-week high of $92.75 before closing the day marginally lower at $92.46.
Chemical Industry Off to a Good Start, 4 Stocks to Buy Now
by Zacks Equity Research
As the chemical industry's upturn is expected to continue in 2017, it will be a prudent idea to zero in on these four stocks with compelling growth prospects.
5 Top ROE Stocks to Buy as Markets Hit Record High
by Supriyo Bose
ROE helps investors distinguish between profit-generating companies from profit burners and is useful for determining the financial health of a company.
Albemarle (ALB) Tops Earnings, Revenue Estimates in Q4
by Zacks Equity Research
Albemarle's (ALB) fourth-quarter earnings and sales topped the respective Zacks Consensus Estimate.
Trump's Tax Cut Plan on the Anvil: 5 ROE Stocks to Buy
by Supriyo Bose
ROE helps investors distinguish between profit-generating companies from profit burners and is useful for determining the financial health of a company.
Celanese (CE) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Celanese Corporation (CE) logged adjusted earnings per share of $1.52 in the reported quarter, up 21.6% from $1.25 reported a year ago which was above the Zacks Consensus Estimate of $1.51.
Chemical Stocks' Earnings Slated on Feb 1: CE, CBT, OMN
by Zacks Equity Research
We take a look at three chemical companies that are slated to report their quarterly results on Feb 1.